BNP and NT-proBNP levels in patients with sepsis

被引：18

作者：

Li, Nan ^{[1
]}

Zhang, Yu ^{[1
]}

Fan, Songtao ^{[2
]}

Xing, Jing ^{[1
]}

Liu, Hongyang ^{[1
]}

机构：

[1] Dalian Med Univ, Emergency Dept, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China

[2] Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2013年 / 18卷

关键词：

Systemic Inflammatory Response Syndrome; B-Type Natriuretic Peptide; Multiple Organ Dysfunction Syndrome; Atrial Natriuretic Peptide; Review; BRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; HEART-FAILURE; SEPTIC SHOCK; VENTRICULAR DYSFUNCTION; PROCALCITONIN; BIOCHEMISTRY; MARKER; EPIDEMIOLOGY; DEPRESSION;

D O I：

10.2741/4175

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Sepsis is a severe complication of critically ill patients that is characterized by the systemic inflammatory response syndrome (SIRS). The increased levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) are related with dysfunction of the cardiovascular system and systemic inflammation. In recent years, BNP and NT-proBNP have been the focus of studies evaluating the severity and prognosis of sepsis. In this study, we will review the role of BNP and NT-proBNP in sepsis.

引用

页码：1237 / 1243

页数：7

共 50 条

[31] Clinical value of NT-ProBNP and BNP in pediatric cardiology
Nir, A
Nasser, N
JOURNAL OF CARDIAC FAILURE, 2005, 11 (05) : S76 - S80
[32] Comparison between BNP and NT-proBNP in pediatric populations
Tawiah, Kwaku
Franks, Caroline E.
Tang, Jessica
Gazit, Avihu
Dietzen, Dennis J.
Farnsworth, Christopher W.
CLINICAL BIOCHEMISTRY, 2022, 109 : 74 - 78
[33] BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era
Sbolli, Marco
deFilippi, Christopher
CURRENT CARDIOLOGY REPORTS, 2020, 22 (11)
[34] BNP、NT-proBNP研究状况及进展
李燕
刘大军
实用药物与临床, 2021, 24 (12) : 1133 - 1136
[35] Use of NT-proBNP in routine testing and comparison to BNP
Pfister, R
Scholz, M
Wielckens, K
Erdmann, E
Schneider, CA
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) : 289 - 293
[36] Brain natriuretic peptide (BNP) and N-terminal proBNP (nt-proBNP) in haemodialysis patients
Racek, J
Kralova, H
Eiselt, J
Trefil, L
Rajdl, D
Jerabek, Z
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V297 - V297
[37] Renal handling of BNP and NT-proBNP in hypertensive subjects
van Kimmenade, RR
Bakker, JA
Houben, AJ
Kroon, AA
Rennenberg, R
Crijns, HJ
van Dieijen-Visser, MP
de Leeuw, PW
Pinto, YM
CIRCULATION, 2005, 112 (17) : U663 - U663
[38] BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era
Marco Sbolli
Christopher deFilippi
Current Cardiology Reports, 2020, 22
[39] NT-proBNP and BNP: biomarkers for heart failure management
Bettencourt, P
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) : 359 - 363
[40] Clinical utility of the cardiac markers BNP and NT-proBNP
Buchner, S
Riegger, G
Luchner, A
ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 144 - 151

← 1 2 3 4 5 →